Rhythm Pharmaceuticals, Inc. RYTM Market capitalization

Market capitalization at other companies

Eli LillyLLY

$1.07T+53.1%

Aardvark Therapeutics, Inc.AARD

$82.25M—

Viking TherapeuticsVKTX

$3.76B+38.7%

Mirum Pharmaceuticals, Inc.MIRM

$7.14B+182%

TG TherapeuticsTGTX

$8.41B+42.0%

Neurocrine BiosciencesNBIX

$13.22B+19.9%

FAQ

What is Rhythm Pharmaceuticals, Inc.'s market capitalization?

Rhythm Pharmaceuticals, Inc. (RYTM) reported market capitalization of $5.94B in Q1 2026.

How has Rhythm Pharmaceuticals, Inc.'s market capitalization changed year-over-year?

Rhythm Pharmaceuticals, Inc.'s market capitalization increased by 77.3% year-over-year, from $3.35B to $5.94B.

What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s market capitalization?

Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s market capitalization has grown at a 36.7% compound annual growth rate (CAGR), from $1.49B to $7.14B.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.